CHPA Requests Extension To Childproof Imidazoline Product Packaging
This article was originally published in The Tan Sheet
Executive Summary
The OTC trade group says firms need two years, twice the time CPSC would allow under a proposed rule, to require child-resistant packaging for drugs with more than 0.08 mg of imidazolines, including such OTCs as Visine eye drops and Afrin nasal decongestants.